Clinical Trial: Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
SARS-CoV-2 RNA Vaccines
HIV Infection
Study Type: Observational
Official Title: Prospective Study to Evaluate the Persistence and Characteristics of Humoral and Cellular Immunity Against SARS-COV-2 After Vaccination in HIV-infected Patients Severely Immunosuppressed
Brief Summary:
Prospective, non-equality, cohort study, where investigators propose to analyze humoral and cellular immunity after two doses of SARS-CoV-2 RNA vaccines in HIV-infected participants severely immunosuppressed.A total of 92 HIV-infected subjects over 18 years old with ?200 CD4/?l (experimental group; n=46) and ? 350 CD4/?l (as control group; n=46) who have completed two doses vaccination against SARS-CoV-2 will be included in the study.Primary Objectives:To analyze the percentage of participants with…
Read more